A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia

Clinical trial NCT04409262 · COMPLETED

Trial details

NCT number: NCT04409262
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2020-06-16
Primary completion: 2021-02-01
Enrollment: 649

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.